Cargando…

IDH1(R132H) in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis

BACKGROUND: The high frequency of mutations in the isocitrate dehydrogenase 1 (IDH1) gene in diffuse gliomas indicates its importance in the process of gliomagenesis. These mutations result in loss of the normal function and acquisition of the neomorphic activity converting α-ketoglutarate to 2-hydr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosiak, Kamila, Smolarz, Maciej, Stec, Wojciech J., Peciak, Joanna, Grzela, Dawid, Winiecka-Klimek, Marta, Stoczynska-Fidelus, Ewelina, Krynska, Barbara, Piaskowski, Sylwester, Rieske, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856348/ https://www.ncbi.nlm.nih.gov/pubmed/27145078 http://dx.doi.org/10.1371/journal.pone.0154726

Ejemplares similares

Cyclic trans-phosphorylation in a homodimer as the predominant mechanism of EGFRvIII action and regulation
por: Stec, Wojciech, et al.
Publicado: (2018)

SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence
por: Winiecka-Klimek, Marta, et al.
Publicado: (2015)

Genetic heterogeneity of RPMI-8402, a T-acute lymphoblastic leukemia cell line
por: STOCZYNSKA-FIDELUS, EWELINA, et al.
Publicado: (2016)

Cell line with endogenous EGFR(vIII) expression is a suitable model for research and drug development purposes
por: Stec, Wojciech J., et al.
Publicado: (2016)

Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system
por: Drozd, Anna M., et al.
Publicado: (2015)

Efficient and simple approach to in vitro culture of primary epithelial cancer cells
por: Janik, Karolina, et al.
Publicado: (2016)

Low Incidence along with Low mRNA Levels of EGFR(vIII) in Prostate and Colorectal Cancers Compared to Glioblastoma
por: Peciak, Joanna, et al.
Publicado: (2017)

PIN3 duplication may be partially responsible for TP53 haploinsufficiency
por: Winiecka-Klimek, Marta, et al.
Publicado: (2014)

Different mutational characteristics of TSG in cell lines and surgical specimens
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2014)

EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line
por: Treda, Cezary, et al.
Publicado: (2016)

Generation of induced neural stem cells with inducible IDH1(R132H) for analysis of glioma development and drug testing
por: Rosiak-Stec, Kamila, et al.
Publicado: (2020)

Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors
por: Walczak, Maciej P., et al.
Publicado: (2016)

The Failure in the Stabilization of Glioblastoma-Derived Cell Lines: Spontaneous In Vitro Senescence as the Main Culprit
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2014)

A way to understand idiopathic senescence and apoptosis in primary glioblastoma cells – possible approaches to circumvent these phenomena
por: Janik, Karolina, et al.
Publicado: (2019)

Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions
por: Piaskowski, S, et al.
Publicado: (2011)

Gaps and Doubts in Search to Recognize Glioblastoma Cellular Origin and Tumor Initiating Cells
por: Wlodarczyk, Aneta, et al.
Publicado: (2020)

Limited importance of the dominant-negative effect of TP53 missense mutations
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2011)

EGFR(vIII): An Oncogene with Ambiguous Role
por: Rutkowska, Adrianna, et al.
Publicado: (2019)

Role of Senescence in Tumorigenesis and Anticancer Therapy
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2022)

Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy
por: Grot, Dagmara, et al.
Publicado: (2022)

Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy
por: Tręda, Cezary, et al.
Publicado: (2023)

Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients
por: Bieńkowski, Michał, et al.
Publicado: (2013)

Proteomic and Transcriptomic Landscapes of Alström and Bardet–Biedl Syndromes
por: Smyczynska, Urszula, et al.
Publicado: (2022)

Successful elimination of non-neural cells and unachievable elimination of glial cells by means of commonly used cell culture manipulations during differentiation of GFAP and SOX2 positive neural progenitors (NHA) to neuronal cells
por: Witusik, Monika, et al.
Publicado: (2008)

Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies
por: Witusik-Perkowska, Monika, et al.
Publicado: (2010)

Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors
por: Rieske, Piotr, et al.
Publicado: (2009)

Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells—EGFRvIII Appears as a Weak Oncogene
por: Włodarczyk, Aneta, et al.
Publicado: (2022)

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
por: Tesileanu, C. Mircea S., et al.
Publicado: (2021)

The prognostic IDH1(R132) mutation is associated with reduced NADP(+)-dependent IDH activity in glioblastoma
por: Bleeker, Fonnet E., et al.
Publicado: (2010)

Generation and Performance of R132H Mutant IDH1 Rabbit Monoclonal Antibody
por: Rashidian, Juliet, et al.
Publicado: (2017)

IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma
por: Lu, Jun, et al.
Publicado: (2014)

Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
por: Cuyàs, Elisabet, et al.
Publicado: (2015)

IDH-1(R132H) mutation status in diffuse glioma patients: implications for classification
por: Wang, Peng-fei, et al.
Publicado: (2016)

Decreased expression of IDH1-R132H correlates with poor survival in gastrointestinal cancer
por: Li, Jieying, et al.
Publicado: (2016)

IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing
por: Lee, Jung Hee, et al.
Publicado: (2017)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

Somatic IDH1 variant (p.R132C) in an adult male with Maffucci syndrome
por: Brown, Natasha J., et al.
Publicado: (2021)

Computational study on novel natural compound inhibitor targeting IDH1_R132H
por: Zhou, Baolin, et al.
Publicado: (2022)

R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition
por: Sears, Thomas K., et al.
Publicado: (2022)

IDH1-R132 changes vary according to NPM1 and other mutations status in AML
por: Falini, Brunangelo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2hhcpl9pnjnivifpcdtnavpekv